FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to compounds of formulas EI-5 and FQ, as well as to their pharmaceutically acceptable salts.
EI-5
FQ.
EFFECT: technical result is obtaining novel compounds which can be used in medicine for treating immunological pathological conditions.
4 cl, 36 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATORS OF ATP-BINDING TRANSPORTERS | 2010 |
|
RU2552353C2 |
| NOVEL COMPOUNDS OF SUBSTITUTED N-(3-FLUOROPROPYL)PYRROLIDINE, METHODS FOR PRODUCTION THEREOF AND THERAPEUTIC APPLICATION THEREOF | 2017 |
|
RU2742278C2 |
| MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE | 2019 |
|
RU2804139C2 |
| PYRUVATEKINASE MODULATORS AND THEIR USE | 2018 |
|
RU2797518C2 |
| NLRP3 INFLAMMASOME INHIBITORS | 2020 |
|
RU2826735C2 |
| GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
| TREATMENT METHOD | 2012 |
|
RU2621148C2 |
| ANTI-PROLIFERATIVE COMPOUNDS AND THEIR APPLICATIONS | 2019 |
|
RU2811969C2 |
| HETEROCYCLIC MAT2A INHIBITORS AND METHODS OF THEIR USE FOR CANCER TREATMENT | 2019 |
|
RU2809987C2 |
| PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2016 |
|
RU2729609C2 |
Authors
Dates
2020-03-04—Published
2016-06-08—Filed